Subsequent Bevacizumab Treatment in Patients With HHT. Follow up BABH
NCT06039124
·
clinicaltrials.gov ↗
COMPLETED
Status
23
Enrollment
OTHER
Sponsor class
Conditions
Hemorrhagic Hereditary Telangiectasia
HHT
Interventions
OTHER:
bevacizumab treatment
Sponsor
Hospices Civils de Lyon